Nanomechanical devices detect disease
The dream of personalised medicine has taken another step towards reality as scientists have developed an innovative nanomechanical sensor for detecting disease and observing the body's reaction to treatment.
The dream of personalised medicine has taken another step towards reality as scientists have developed an innovative nanomechanical sensor for detecting disease and observing the body's reaction to treatment.
India has been stepping up efforts to streamline the process of clinical research.
A more spontaneous future for sufferers of erectile dysfunction has been heralded by the successful completion of a Phase I clinical trial of a new gene therapy which could provide six months' effect with a single dose.
The UK subsidiary of ProMetic Life Sciences has signed a deal with Novartis to develop a new purification technology for recombinant protein vaccines that is claimed to be more efficient and cheaper than currently used methods.
New flow reactor heater allows high-speed, multi-step reactions in front of your eyes allowing users to monitor progress and intervene in case problems to avoid time and reagent waste.
Intertek has broadened its portfolio to offer outsourced analysis of biologics as well as small molecules by purchasing Alta Laboratories, for $25m (€18.8m).
Nastech missed out on a $15m (€11m) milestone payment after having to delay the development of its new nasal spray for the treatment of osteoporosis because of the need of an additional clinical trial.
A late night compromise on controversial EU legislation on chemical control - REACH - means it could now come into play as planned in 2007.
Before deciding what part of a clinical trial to outsource, one of the most important things a sponsor should do is define its core competencies and then outsource accordingly.
A federal scientist has been charged with criminal conflict of interest after he allegedly performed consultancy work that improperly overlapped with government work.